Lonza Upgrades Organic Growth Model And Mid-Term Financial Ambitions At Capital Markets Day

By Reuters News

- LONZA GROUP AG LONN.S:

  • UPGRADES ORGANIC GROWTH MODEL AND MID-TERM FINANCIAL AMBITIONS AT CAPITAL MARKETS DAY; Q3 2026 IN LINE WITH EXPECTATIONS

  • MODEL TARGETS 10-13% ORGANIC CER SALES GROWTH AND CORE EBITDA MARGIN IN HIGH THIRTIES MID-TERM

  • CONFIRMS UPGRADED FULL-YEAR 2026 OUTLOOK

  • EXPECTS NEGATIVE FX IMPACT OF 2% TO 3% ON 2026 SALES GROWTH

  • EXPECTS MID-SINGLE-DIGIT CER SALES GROWTH AND CORE EBITDA MARGIN EXPANSION IN CAPSULES & HEALTH INGREDIENTS FOR 2026

  • REITERATES FULL-YEAR 2026 OUTLOOK OF 11–12% CER SALES GROWTH AND CORE EBITDA MARGIN OF 33–34%

  • LONZA UPGRADES ITS ORGANIC GROWTH MODEL OF LOW-TEENS ORGANIC CER SALES GROWTH ON AVERAGE OVER TIME WITH AN ACCELERATION OF CORE EBITDA MARGIN EXPANSION, NOW REACHING HIGH THIRTIES IN MID-TERM

  • IT ALSO EXPANDS MODEL TO INCLUDE A MID-TERM ROIC AMBITION OF TWO TO THREE TIMES TODAY'S WACC AND AN IMPROVING FCF CONVERSION ON AVERAGE OVER TIME, REFLECTING ITS DISCIPLINED INVESTMENT APPROACH AND OVERALL GREATER CAPITAL EFFICIENCY

  • UNCHANGED, ORGANIC CAPEX IS EXPECTED TO FLUCTUATE AROUND MID-TO-HIGH TEENS PERCENTAGE OF SALES, WHILE LONZA REMAINS COMMITTED TO A PROGRESSIVE DIVIDEND DISTRIBUTION, ALL IN LINE WITH ITS CAPITAL ALLOCATION FRAMEWORK FIRST SHARED IN 2024

Further company coverage: LONN.S

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk